Status:
UNKNOWN
A Comparison of Invasive and Non-invasive Measurement of CI and SVR in Liver Transplantation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Living Donor Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients who are scheduled to receive living donor liver transplantation will be monitored with a radial and femoral arterial line. A pulmonary artery catheter will also be placed and central venous p...
Detailed Description
In many end stage liver disease patients, cardiac output (CO) is increased and systemic vascular resistance (SVR) is decreased. During liver transplantation it is common to see hemodynamic instability...
Eligibility Criteria
Inclusion
- routine living donor liver transplantation recipients needing pulmonary artery catheterization who have been informed and given consent
Exclusion
- Patients with atrial fibrillation
- Contraindications to pulmonary artery catheterization or needing attention to insertion of pulmonary artery catheter: right-sided endocarditis, tumors, right sided valvular disease, left bundle branch block
- Patients with obstructive vascular disease in the upper extremities, anatomical deformities in the upper extremities, Raynaud syndrome, etc.
Key Trial Info
Start Date :
May 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 28 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04909645
Start Date
May 31 2021
End Date
May 28 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea